EATRIS, the European Research Infrastructure for Translational Medicine, and Biocat, the cluster organisation of life sciences and healthcare innovation in Catalonia, join forces to propose this forum within the frame of iNext-Discovery, an H2020 project enabling access to structural biology research infrastructures for all European researchers.
The 13-14 of June, they will meet up in Parc Científic de Barcelona for this Public-Private Forum “From Molecules To Treatments: Business Models For New Drug Discovery”.
This event is designed for:
- Biomedical Researchers with interest and/or first experience in working with industry
- Scientific Infrastructures, platforms and research centres (e.g. target providers, biobanks, libraries of compounds) that participate in early drug development and want to understand the commercialisation and partnering landscape
- Entrepreneurs and researchers aiming to develop a business activity (e.g. start-up, spin-off, licence, co-development)
- Corporates that want to learn about challenges and ideas in academia
- Research Institutes linked to hospitals providing or requiring scientific underpinning for new drug Discovery
Registration is free but it has limited capacity, click here to register and discover more about the event: FROM MOLECULES TO TREATMENTS
